Skip to content

Vir Biotechnology, Inc. VIR Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$189.67B+13.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2B+82.0%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.45B+32.4%
Nuvation Bio logo
Nuvation BioNUVB
$1.49B+150%

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Computed from the period-end share price: $1.43B.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s market capitalization?
Vir Biotechnology, Inc. (VIR) reported market capitalization of $1.43B in Q1 2026.
How has Vir Biotechnology, Inc.'s market capitalization changed year-over-year?
Vir Biotechnology, Inc.'s market capitalization increased by 61.1% year-over-year, from $888.69M to $1.43B.
What is the long-term trend for Vir Biotechnology, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s market capitalization has grown at a -24.9% compound annual growth rate (CAGR), from $3.5B to $838.92M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.